Fig. 1

Example of gating strategies used for immunophenotype analysis on PBMCs collected from 20 subjects, including 9 young individuals (aged 18–35 years) and 11 older adults (aged > 60 years), before the administration of the influenza vaccine (T0) and 21–28 days post-vaccination (T1)